Precision BioSciences Operating Expenses 2011-2026 | DTIL

Annual Operating Expenses Precision BioSciences

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
92.5 M	87.4 M	155 M	134 M	109 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
155 M	87.4 M	116 M

Quarterly Operating Expenses Precision BioSciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
20.7 M	21.9 M	22.1 M	-	21.9 M	25.8 M	21.8 M	-	25.5 M	22.9 M	22.1 M	-	22 M	33.4 M	30.7 M	-	35.6 M	47.2 M	35.1 M	-	33.4 M	33.9 M	34.5 M	-	26.8 M	29.3 M	25 M	-	13 M	14 M	10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
47.2 M	10.8 M	26.2 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Aptorum Group Limited APM	20.7 M	$ 0.84	2.78 %	$ 4.58 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Amarin Corporation plc AMRN	233 M	$ 15.08	2.24 %	$ 6.15 B	Irlanda
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.51	-1.68 %	$ 8.45 B	Australia
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	338 M	$ 222.25	0.1 %	$ 5 B	Danmark
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	512 M	$ 109.88	-0.42 %	$ 27.2 B	Germany
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	106 M	$ 9.21	2.56 %	$ 1.48 B	Britain
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	74.7 M	$ 2.64	7.99 %	$ 3.08 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 4.4	2.8 %	$ 9.57 B	Israel
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.44	-1.37 %	$ 367 M	Britain
Amneal Pharmaceuticals AMRX	539 M	$ 14.79	1.83 %	$ 4.57 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA